Skip to content

Zip-Stitch™ for Vaginal Cuff Closure in Total Laparoscopic Hysterectomy

Zip-Stitch™ for Vaginal Cuff Closure in Total Laparoscopic Hysterectomy: First in Human Ease of Use Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03310658
Enrollment
10
Registered
2017-10-16
Start date
2017-04-17
Completion date
2018-05-30
Last updated
2018-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Laparoscopic Hysterectomy

Brief summary

ZSX Medical completed enrollment in its First in Human Ease of Use study in May of 2017, in Monterrey Mexico. The purpose of this study is to demonstrate the ease of use of Zip-Stitch™, to generate first in human data, and to refine surgical technique of the device. Ten subjects were enrolled and received total laparoscopic hysterectomies, including vaginal cuff closure with the Zip-Stitch™ system during their otherwise standard care. Procedures took place over the course of one week. Subjects had in person follow-up appointments at 1 and 6 weeks. Subjects are continuing follow-up through a one-year extension period which will end in May 2018.

Interventions

DEVICEZip-Stitch Soft Tissue Closure System

The novel Zip-Stitch System employed a laparoscopic applicator, a series of bio-absorbable clips, and an application procedure to close the vaginal cuff during otherwise standard of care total laparoscopic hysterectomy.

Sponsors

ZSX Medical LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of signed and dated Informed Consent Form * Stated willingness to comply with all study procedures, including participation in follow-up visits and telephonic follow-up * Female, age 18 years or older * Indicated for Total Laparoscopic Hysterectomy

Exclusion criteria

* HIV * Hepatitis C * Diabetics * Use of systemic corticosteroids * History of pelvic irradiation * Active infection * History of bleeding problems/hemophilia * Cancer * Cases in which vaginal cuff closure is intended to be performed robotically * Pregnant

Design outcomes

Primary

MeasureTime frameDescription
Device Ease of UseImmediately following procedureEase of Use of the Zip-Stitch Soft Tissue Closure System during Total Laparoscopic Hysterectomy. Assessed following surgery by standardized surgeon interview.

Secondary

MeasureTime frameDescription
Vaginal Cuff ClosureDuring procedure.Assessment of quality of vaginal cuff closure following uterine excision. Performed by surgeon as operative standard of care.
Vaginal Cuff Closure TimeDuring Procedure.Procedural time from uterine excision to successful vaginal cuff closure.
Total Surgical TimeDuring Procedure.Total procedural time.
Device Use Learning Curve assessed with a Surgeon SurveyAssessed immediately following study completion during surgeon survey.Investigation of change in effectiveness of device implementation as assessed by change in efficiency of device use.
Sexual DiscomfortAssessed at 1 and 6 week follow-up visits.Measurement of subject discomfort during sexual activity following completion of surgical procedure. Assessed with 1-10 scale (1 = No Pain, 10 = Most Pain).

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026